{"title":"Henry Liu","description":"\u003cp\u003e\u0026lt;p\u0026gt;Henry Liu, MD\u0026lt;br\u0026gt;University of Pennsylvania Perelman School of Medicine\u0026lt;br\u0026gt;Anesthesiology \u0026amp;amp; Critical Care Medicine\u0026lt;br\u0026gt;Philadelphia, PA 19104\u0026lt;br\u0026gt;USA\u0026lt;\/p\u0026gt;\u003cbr\u003e\u0026lt;p\u0026gt;\u0026amp;nbsp;\u0026lt;\/p\u0026gt;\u003cbr\u003e\u0026lt;p\u0026gt;Dr. Alan David Kaye, MD, PhD, DABA, DABPM, DABIPP, FASA\u0026lt;\/p\u0026gt;\u003cbr\u003e\u0026lt;p\u0026gt;\u0026lt;span style=\"font-size: 11.0pt; font-family: 'Aptos',sans-serif; mso-fareast-font-family: Aptos; mso-fareast-theme-font: minor-latin; mso-bidi-font-family: Aptos; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA;\"\u0026gt;Former\u0026amp;nbsp;\u0026lt;\/span\u0026gt;Vice-Chancellor of Academic Affairs, Chief Academic Officer, and Provost,\u0026amp;nbsp;\u0026lt;\/p\u0026gt;\u003cbr\u003e\u0026lt;p\u0026gt;\u0026lt;span style=\"font-size: 11.0pt; font-family: 'Aptos',sans-serif; mso-fareast-font-family: Aptos; mso-fareast-theme-font: minor-latin; mso-bidi-font-family: Aptos; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA;\"\u0026gt;Vice Chairman, Research on Interventional Pain\u0026lt;\/span\u0026gt;\u0026lt;\/p\u0026gt;\u003cbr\u003e\u0026lt;p\u0026gt;\u0026lt;span style=\"font-size: 11.0pt; font-family: 'Aptos',sans-serif; mso-fareast-font-family: Aptos; mso-fareast-theme-font: minor-latin; mso-bidi-font-family: Aptos; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA;\"\u0026gt;Fellowship Director, Department of Anesthesiology\u0026amp;nbsp;\u0026lt;\/span\u0026gt;\u0026lt;\/p\u0026gt;\u003cbr\u003e\u0026lt;p\u0026gt;\u0026lt;span style=\"font-size: 11.0pt; font-family: 'Aptos',sans-serif; mso-fareast-font-family: Aptos; mso-fareast-theme-font: minor-latin; mso-bidi-font-family: Aptos; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA;\"\u0026gt;Professor, Department of Pharmacology, Toxicology and Neurosciences\u0026lt;\/span\u0026gt;\u0026lt;\/p\u0026gt;\u003cbr\u003e\u0026lt;p\u0026gt;Tenured Professor of Anesthesiology and Pharmacology, Toxicology, and Neurosciences,\u0026amp;nbsp;\u0026lt;\/p\u0026gt;\u003cbr\u003e\u0026lt;p\u0026gt;Pain Fellowship Program Director,\u0026amp;nbsp;\u0026lt;\/p\u0026gt;\u003cbr\u003e\u0026lt;p\u0026gt;LSU School of Medicine,\u0026amp;nbsp;1501 Kings Hwy, Shreveport, LA 71103\u0026lt;\/p\u0026gt;\u003cbr\u003e\u0026lt;p\u0026gt;\u0026amp;nbsp;\u0026lt;\/p\u0026gt;\u003cbr\u003e\u0026lt;p\u0026gt;\u0026amp;nbsp;\u0026lt;\/p\u0026gt;\u003cbr\u003e\u0026lt;p class=\"MsoNormal\"\u0026gt;Jonathan S. Jahr, MD, PhD, DABA, FASA\u0026lt;\/p\u0026gt;\u003cbr\u003e\u0026lt;p class=\"MsoNormal\"\u0026gt;Professor Emeritus of Anesthesiology and Perioperative Medicine\u0026amp;nbsp;\u0026lt;\/p\u0026gt;\u003cbr\u003e\u0026lt;p class=\"MsoNormal\"\u0026gt;Emeritus Chair of the Faculty, Faculty Executive Committee, David Geffen School of Medicine at UCLA\u0026lt;\/p\u0026gt;\u003cbr\u003e\u0026lt;p class=\"MsoNormal\"\u0026gt;Ronald Reagan UCLA Medical Center\u0026lt;\/p\u0026gt;\u003cbr\u003e\u0026lt;p class=\"MsoNormal\"\u0026gt;757 Westwood Plaza, Suite 3325\u0026lt;\/p\u0026gt;\u003cbr\u003e\u0026lt;p class=\"MsoNormal\"\u0026gt;Los Angeles, California 90095\u0026lt;\/p\u0026gt;\u003c\/p\u003e","products":[{"product_id":"blood-substitutes-and-oxygen-biotherapeutics-henry-liu-ebook","title":"Blood Substitutes and Oxygen Biotherapeutics","description":"\u003cp\u003eBiochemistry of Hemoglobin and Hemoglobin-Based Oxygen Carrier.- Platelet Mimicry for Biomechanical Function.- HBOC Impact Upon Vasoactive Effectors, Rheology and Blood Flow.- Recombinant Hemoglobins with Enhanced Oxydative Stability.- Nitric Oxide Protectants as a Potential Adjunct of HBOCs.- Non-hemoglobin Engineered Protein Oxygen Carriers: Omniox.- Metal-Organic Framework-Based Oxygen Carriers.- Coupled Cross-Linked Human Hemoglobins (Bis-Tetramers) Overcome HBOC Problems.- Hemoglobin-based Oxygen Carriers, Oxidative Stress and Myocardial Infarction – Issues and Implications for HBOC Development.- Fractionated Polymerized Hemoglobin-A Modernized Erythrocytic Substitute and Oxygen Biotherapeutic.- Hemoglobin-Based Oxygen Carriers: Toxicity Mechanisms and Molecular Mitigation Strategies.- Nitric Oxide and Hemoglobin: physiological implications.- Ideal P50: The Ability to Design Artificial Oxygen Carriers and to Create a Product that Self Regulates.- Hemoglobin-Based Oxygen Carriers: Evolving Concepts and Clinical Implications.- HBOC Design Using Protein Engineering.- Pegylated Bovine Hemoglobin: Manufacturing and Characterization.- Benefits and risks of encapsulated Hb as an artificial oxygen carrier.- Cardiovascular Effects of Hemoglobin-Based Oxygen Carriers.- Perfluorocarbon-based Oxygen Carriers: A Comprehensive Overview.- Expanded Access when Blood Not an Option: Use of Hemopure and Sanguinate.- Perfluorocarbon-based artificial oxygen carriers for kidney and heart perfusion.- Perfluorocarbon-based Artificial Oxygen Carriers for Ex Vivo Organ Perfusion.- The Erythrocruorins as Synthetic Blood Products: What Is New?.- Whole Blood vs Blood Component Therapy.- Biosynthetic Blood Components: Use Case for Hemorrhagic Shock and Clinical Trial Design.- Phase I clinical trial of hemoglobin vesicles (HbV).- Blinded, Randomized, Controlled Trials of HBOC-201 (Hemopure).- Clinical Development and Therapeutic Applications of Clinical Development and Therapeutic Applications of SANGUINATE (PP-007).- Real-Time Circulating Blood Volume Measurements Using Hemoglobin-based Oxygen Carriers: A Novel Alternative to Traditional Methods.- YQ23: A New Hemoglobin Based Oxygen Carrier in Critical Limb Ischemia — Phase I\/II Trials.- The Therapeutic Potential of Plasma Extracellular Vesicles.- Pathogen Reduction for Novel Blood Product Development.- Prothrombin Complex Concentrate as a Therapeutic in Trauma.- The Regenerative Properties of Plasma in Burns.- The Role of Cryoprecipitate in Trauma-Induced Hemorrhagic Shock and Endotheliopathy.- Plasma versus Factor Concentrates Therapy.- The Endotheliopathy of Trauma Patients with Plasma Product Transfusion: Emerging Clinical Developments.- Solvent\/Detergent-Treated Pooled Plasma Products and Factor Concentrates.- Freeze Dried Plasma.- Platelets-Fibrin-RBC Interactions in Hemostatic Clots.- Apheresis Platelet Product Functional Variability.- SynthoPlate and Related Platelet-Inspired Synthetic Nanotechnologies for Hemorrhage Control.- Blood Substitutes Related Regulatory Updates (FDA\/CBER).- Innovative Pre-Clinical Models to Prepare Products for FDA Review.- The Regulatory Challenges of Producing Dried Plasma or What’s a Regulator to Do?.- The addition of a simple aqueous solution of synthetic neocatalase, neosuperoxide dismutase and neocarbonic anhydrase improve the effectiveness of oxygen carriers for the preservation of warm ischemic cell\/tissue.- A Military-Civilian Partnership Model to Advance Commercialization of Blood Products.- Acute Safety Study of the Intravenous Injection of a Lyophilized Form of an Extracellular Hemoglobin, M101, in the Rat.\u003c\/p\u003e","brand":"Henry Liu","offers":[{"title":"Default Title","offer_id":54323683426631,"sku":"9783032226563","price":234.33,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0920\/5455\/2903\/files\/blood-substitutes-and-oxygen-biotherapeutics-ebook-cover.webp?v=1783716041"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0920\/5455\/2903\/collections\/henry-liu-autor-kollektion.webp?v=1783716038","url":"https:\/\/www.cinebuch.de\/collections\/henry-liu.oembed","provider":"CineBuch","version":"1.0","type":"link"}